Antifungal susceptibility of invasiveCandidabloodstream isolates from the Asia-Pacific region

Antifungal Susceptibilities of Candida Isolates Causing Bloodstream Infections at a Medical Center in Taiwan, 2009-2010

(2014) Yu-Tsung Huang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance

(2014) Meng Xiao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of New Antifungal Breakpoints on Antifungal Resistance in Candida Species

(2014) A. W. Fothergill et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Regional data analysis ofCandidanon-albicansstrains collected in United States medical sites over a 6-year period, 2006-2011

(2014) Michael A. Pfaller et al.   MYCOSES

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for IdentifyingFKSMutant Candida glabrata Strains and Echinocandin Resistance

(2013) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

(2013) Marcio Nucci et al.   PLoS One

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes

(2011) D. N. Shah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

(2010) M. Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology of invasive candidiasis

(2010) Maiken C Arendrup   Current Opinion in Critical Care

Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

(2010) D. A. Oxman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

(2010) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

(2010) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole

(2010) R. J. Kothavade et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Multicenter surveillance of species distribution and antifungal susceptibilities ofCandidabloodstream isolates in South Korea

(2010) Sook-In Jung et al.   MEDICAL MYCOLOGY

Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region

(2009) Po-Ren Hsueh et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study

(2009) Thean Y. Tan et al.   MYCOSES